摘要
Biological drugs face significant therapeutic hurdles due to their inherent instability and rapid systemic clearance. To address these challenges, this study developed a novel thermosensitive injectable hydrogel composed of carboxymethyl chitosan (CMCs), hyaluronic acid (HA), and β-glycerophosphate (GP). A key innovation involves the incorporation of mesoporous silica nanoparticles (MSNs) to create an organic–inorganic hybrid system (CMHGMs) with enhanced structural integrity and electrostatic affinity for cationic therapeutics. The results demonstrated that MSNs significantly optimised the network, reducing the gelation time from 2.7 min to approximately 1.4 min at 37 °C. Furthermore, the CMHGMs hydrogel exhibited superior sustained release profiles for lidocaine and lysozyme over 14 days, effectively suppressing the initial burst release. The system maintained excellent in vitro injectability through a 26G needle and showed high biocompatibility across in vitro , in ovo , and in vivo models. With a predicted biodegradation period of approximate 3.7 weeks, this hybrid hydrogel serves as a promising, minimally invasive drug depot for prolonged therapeutic delivery in modern clinical and biomedical applications.
危险品化学品经营许可证(带存储)